Protara Therapeutics Inc. (TARA) NASDAQ

$2.70 (0.05) (-1.82%)

Market Cap: $31.44M

As of 04/19/24 10:19 AM EDT. Market open.

(TARA)

Protara Therapeutics Inc. (TARA)
NASDAQ

$2.70
(0.05) (-1.82%)

Market Cap: $31.44M

As of 04/19/24 10:19 AM EDT. Market open.

Add to Portfolio

protara therapeutics, inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. the company's lead program is tara-002, an investigational cell therapy for the treatment of lymphatic malformations. it also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the ... read more

protara therapeutics, inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. the company's lead program is tara-002, an investigational cell therapy for the treatment of lymphatic malformations. it also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. the company was formerly known as artara therapeutics, inc. and changed its name to protara therapeutics, inc. in may 2020. protara therapeutics, inc. is based in new york, new york. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Jesse Shefferman
Full Time Employees
33
URL
Address
1 Little West 12Th Street, New York, New York, 10014.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Jesse Shefferman
Full Time Employees
33
Address
1 Little West 12Th Street, New York, New York, 10014.
PRICE CHART FOR PROTARA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.72
Previous Close
$2.75
Days Range
$2.66 - $2.85
52 week range
$1.04 - $5.24
Volume
68,943
Avg. Volume (30 days)
584,214
Market Cap
$31.44M
Dividend Yield
-
P/E
-
Shares Outstanding
11,433,837
Open
$2.72
Previous Close
$2.75
Days Range
$2.66 - $2.85
52 week range
$1.04 - $5.24
Volume
68,943
Avg. Volume (30 days)
584,214
Market Cap
$31.44M
Dividend Yield
-
P/E
-
Shares Outstanding
11,433,837
FINANCIAL STATEMENTS FOR PROTARA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PROTARA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Shefferman JesseCEO and PresidentJan 19, 2024 Option Exercise$1.917,80314,904944,064Jan 23, 2024, 04:05 PM
Bandari JathinChief Medical OfficerJan 19, 2024 Option Exercise$1.912,8795,49956,704Jan 23, 2024, 04:05 PM
Zummo JacquelineChf Scientific Operations OffJan 19, 2024 Option Exercise$1.913,0495,824104,296Jan 23, 2024, 04:05 PM
Fry HannahVP, ControllerJan 19, 2024 Option Exercise$1.919041,72729,836Jan 23, 2024, 04:05 PM
Shefferman JesseCEO and PresidentJan 10, 2024 Option Exercise$2.395,74613,733892,867Jan 12, 2024, 04:05 PM
Zummo JacquelineChf Scientific Operations OffJan 10, 2024 Option Exercise$2.395,22912,49784,345Jan 12, 2024, 04:05 PM
Bandari JathinChief Medical OfficerJan 10, 2024 Option Exercise$2.391,8774,48636,583Jan 12, 2024, 04:05 PM
Zummo JacquelineChf Scientific Operations OffJan 03, 2024 Option Exercise$2.171,8994,12189,574Jan 05, 2024, 04:35 PM
Shefferman JesseCEO and PresidentJan 03, 2024 Option Exercise$2.175,84012,673898,613Jan 05, 2024, 04:30 PM
Fry HannahVP, ControllerJan 03, 2024 Option Exercise$2.1732470322,740Jan 05, 2024, 04:05 PM
Fry HannahVP, ControllerJul 17, 2023 Option Exercise$2.5610,07525,79223,064Jul 18, 2023, 04:05 PM
Bandari JathinChief Medical OfficerJul 03, 2023 Option Exercise$2.466821,67838,460Jul 05, 2023, 04:05 PM
Zummo JacquelineChf Scientific Operations OffJan 10, 2023 Option Exercise$3.005,22515,67571,573Jan 11, 2023, 04:05 PM
Shefferman JesseCEO and PresidentJan 10, 2023 Option Exercise$3.005,85517,565866,982Jan 11, 2023, 04:03 PM
Bandari JathinChief Medical OfficerJan 10, 2023 Option Exercise$3.001,8765,62818,442Jan 11, 2023, 04:02 PM
Zummo JacquelineChf Scientific Operations OffJan 03, 2023 Option Exercise$2.802,1596,04576,798Jan 04, 2023, 04:26 PM
Shefferman JesseCEO and PresidentJan 03, 2023 Option Exercise$2.806,60418,491872,837Jan 04, 2023, 04:25 PM
Fry HannahVP, ControllerJan 03, 2023 Option Exercise$2.803611,01127,239Jan 04, 2023, 04:24 PM
Opaleye Management Inc.10% OwnerDec 30, 2022 Sale$2.712,3006,236130,000Dec 30, 2022, 06:00 PM
Opaleye Management Inc.10% OwnerDec 30, 2022 Sale$2.7113,17335,7132,562,594Dec 30, 2022, 06:00 PM
Opaleye Management Inc.10% OwnerSep 15, 2022 Buy$3.805,00019,0002,575,777Sep 15, 2022, 04:05 PM
Opaleye Management Inc.10% OwnerSep 14, 2022 Buy$3.982,5009,950130,000Sep 15, 2022, 04:05 PM
Opaleye Management Inc.10% OwnerSep 14, 2022 Buy$3.9814,10056,1182,570,777Sep 15, 2022, 04:05 PM
Opaleye Management Inc.10% OwnerSep 15, 2022 Buy$3.802,3008,740132,300Sep 15, 2022, 04:05 PM
Shefferman JesseCEO and PresidentAug 11, 2022 Buy$3.849,06534,810879,441Aug 15, 2022, 05:49 PM
Davis BlaineChief Financial OfficerJul 15, 2022 Option Exercise$3.135,08115,90420,662Jul 19, 2022, 04:31 PM
Bandari JathinChief Medical OfficerJul 01, 2022 Option Exercise$3.226822,19620,318Jul 05, 2022, 05:00 PM
BESHAR LUKE MDirectorJun 30, 2022 Buy$3.1010,00031,000198,000Jul 05, 2022, 05:00 PM
Opaleye Management Inc.10% OwnerApr 08, 2022 Buy$4.802,46911,841127,500Apr 15, 2022, 06:15 AM
Opaleye Management Inc.10% OwnerApr 08, 2022 Buy$4.805,32225,5232,556,667Apr 15, 2022, 06:15 AM
Opaleye Management Inc.10% OwnerApr 07, 2022 Buy$4.741,0004,743125,031Apr 15, 2022, 06:15 AM
Opaleye Management Inc.10% OwnerApr 07, 2022 Buy$4.741,3456,3802,551,345Apr 15, 2022, 06:15 AM
Opaleye Management Inc.10% OwnerApr 08, 2022 Buy$4.805,32225,5232,556,667Apr 08, 2022, 06:45 PM
Opaleye Management Inc.10% OwnerApr 07, 2022 Buy$4.741,0004,743125,031Apr 08, 2022, 06:45 PM
Opaleye Management Inc.10% OwnerApr 07, 2022 Buy$4.741,3456,3802,551,345Apr 08, 2022, 06:45 PM
Opaleye Management Inc.10% OwnerApr 08, 2022 Buy$4.802,46911,841128Apr 08, 2022, 06:45 PM
BESHAR LUKE MDirectorMar 14, 2022 Buy$4.2510,00042,500188,000Mar 16, 2022, 04:37 PM
BESHAR LUKE MDirectorMar 10, 2022 Buy$4.4610,00044,555178,000Mar 14, 2022, 04:37 PM
Opaleye Management Inc.10% OwnerJan 28, 2022 Buy$4.964,03120,007124,031Jan 31, 2022, 04:05 PM
Opaleye Management Inc.10% OwnerJan 28, 2022 Buy$4.9620,00099,2642,550,000Jan 31, 2022, 04:05 PM
Zummo JacquelineChf Scientific Operations OffJan 10, 2022 Option Exercise$6.274,60328,86178,957Jan 12, 2022, 05:20 PM
Shefferman JesseCEO and PresidentJan 10, 2022 Option Exercise$6.275,08031,852872,425Jan 12, 2022, 05:18 PM
Opaleye Management Inc.10% OwnerDec 29, 2021 Buy$6.984,50031,408120,000Dec 29, 2021, 07:36 PM
Opaleye Management Inc.10% OwnerDec 28, 2021 Buy$6.365,50034,973115,500Dec 29, 2021, 07:36 PM
Opaleye Management Inc.10% OwnerDec 28, 2021 Buy$6.361,59110,1172,530,000Dec 29, 2021, 07:36 PM
Opaleye Management Inc.10% OwnerDec 23, 2021 Buy$6.608005,280105,000Dec 27, 2021, 06:52 PM
Opaleye Management Inc.10% OwnerDec 23, 2021 Buy$6.605003,3002,496,709Dec 27, 2021, 06:52 PM
Opaleye Management Inc.10% OwnerDec 27, 2021 Buy$6.535,00032,659110,000Dec 27, 2021, 06:52 PM
Opaleye Management Inc.10% OwnerDec 27, 2021 Buy$6.5331,700207,0552,528,409Dec 27, 2021, 06:52 PM
Opaleye Management Inc.10% OwnerDec 20, 2021 Buy$6.497034,5622,496,209Dec 22, 2021, 04:05 PM
Opaleye Management Inc.10% OwnerDec 16, 2021 Buy$6.416,50041,6702,493,206Dec 20, 2021, 04:00 PM
Opaleye Management Inc.10% OwnerDec 17, 2021 Buy$6.604903,234104,200Dec 20, 2021, 04:00 PM
Opaleye Management Inc.10% OwnerDec 17, 2021 Buy$6.602,30015,1802,495,506Dec 20, 2021, 04:00 PM
Opaleye Management Inc.10% OwnerDec 16, 2021 Buy$6.411,0636,815103,710Dec 20, 2021, 04:00 PM
Opaleye Management Inc.10% OwnerNov 18, 2021 Buy$6.981,0006,979102,647Nov 19, 2021, 04:10 PM
Opaleye Management Inc.10% OwnerNov 18, 2021 Buy$6.9814,20699,1512,486,706Nov 19, 2021, 04:10 PM
Opaleye Management Inc.10% OwnerNov 17, 2021 Buy$6.981,0907,608101,647Nov 19, 2021, 04:10 PM
Opaleye Management Inc.10% OwnerNov 17, 2021 Buy$6.988,02856,0352,472,500Nov 19, 2021, 04:10 PM
Opaleye Management Inc.10% OwnerNov 04, 2021 Buy$6.505573,621100,557Nov 08, 2021, 02:30 PM
Opaleye Management Inc.10% OwnerNov 04, 2021 Buy$6.506,00039,0002,464,472Nov 08, 2021, 02:30 PM
Zummo JacquelineChf Scientific Operations OffJan 11, 2021 Option Exercise$21.164,65398,45769,460Jan 13, 2021, 05:19 PM
Shefferman JesseCEO and PresidentJan 11, 2021 Option Exercise$21.165,069107,260835,205Jan 13, 2021, 05:16 PM
Opaleye Management Inc.10% OwnerSep 30, 2020 Buy$16.0050,000800,0002,458,472Oct 02, 2020, 06:05 AM
Opaleye Management Inc.10% OwnerSep 24, 2020 Buy$16.87200,0003,374,0002,408,472Sep 25, 2020, 12:00 AM
Opaleye Management Inc.10% OwnerSep 24, 2020 Buy$16.87100,0001,687,000100,000Sep 25, 2020, 12:00 AM
Davis BlaineChief Financial OfficerSep 22, 2020 Buy$16.911,48125,0381,481Sep 23, 2020, 09:20 AM
Marshall RandallFormer 10% OwnerSep 14, 2020 Sale$19.402,55449,541586,074Sep 15, 2020, 06:04 PM
Marshall Randall10% OwnerSep 10, 2020 Sale$18.002394,302588,154Sep 14, 2020, 04:37 PM
Marshall Randall10% OwnerSep 09, 2020 Sale$18.6610,222190,766593,306Sep 10, 2020, 03:58 PM
Marshall Randall10% OwnerSep 08, 2020 Sale$18.943,10858,866598,615Sep 10, 2020, 03:58 PM
Marshall Randall10% OwnerSep 03, 2020 Sale$20.19521,050601,723Sep 04, 2020, 04:39 PM
Marshall Randall10% OwnerSep 02, 2020 Sale$20.682074,281601,775Sep 04, 2020, 04:39 PM
Marshall Randall10% OwnerAug 28, 2020 Sale$22.0977117,031601,982Sep 01, 2020, 04:53 PM
Marshall Randall10% OwnerAug 27, 2020 Sale$22.3761613,780602,753Aug 28, 2020, 03:56 PM
Marshall Randall10% OwnerAug 26, 2020 Sale$22.401,41831,763603,369Aug 28, 2020, 03:56 PM
Marshall Randall10% OwnerAug 25, 2020 Sale$22.732,46155,939604,787Aug 26, 2020, 04:27 PM
Marshall Randall10% OwnerAug 24, 2020 Sale$23.1697422,558607,248Aug 26, 2020, 04:27 PM
Marshall Randall10% OwnerAug 20, 2020 Sale$24.1851012,333608,222Aug 24, 2020, 09:51 AM
Marshall Randall10% OwnerAug 18, 2020 Sale$25.192005,038608,732Aug 20, 2020, 04:18 PM
Marshall Randall10% OwnerAug 17, 2020 Sale$25.111,54838,870608,932Aug 18, 2020, 05:48 PM
Marshall Randall10% OwnerAug 14, 2020 Sale$25.0970017,563610,480Aug 18, 2020, 05:48 PM
Marshall Randall10% OwnerJul 30, 2020 Sale$26.141,31734,426611,180Jul 31, 2020, 04:59 PM
Marshall Randall10% OwnerJul 29, 2020 Sale$26.422,51666,483613,197Jul 31, 2020, 04:59 PM
Marshall Randall10% OwnerJul 28, 2020 Sale$30.5425,597781,797638,010Jul 29, 2020, 04:40 PM
Marshall Randall10% OwnerJul 27, 2020 Sale$26.083388,815640,610Jul 29, 2020, 04:40 PM
Marshall Randall10% OwnerJul 24, 2020 Sale$26.003007,800640,948Jul 27, 2020, 04:07 PM
Marshall Randall10% OwnerJul 23, 2020 Sale$26.612,04354,369641,341Jul 27, 2020, 04:07 PM
Marshall Randall10% OwnerJul 22, 2020 Sale$26.731,37236,675643,366Jul 23, 2020, 04:31 PM
Marshall Randall10% OwnerJul 21, 2020 Sale$26.562235,923644,663Jul 23, 2020, 04:31 PM
Marshall Randall10% OwnerJul 20, 2020 Sale$26.872,72973,327645,358Jul 21, 2020, 04:44 PM
Marshall Randall10% OwnerJul 17, 2020 Sale$26.661,60142,683647,615Jul 21, 2020, 04:44 PM
Marshall Randall10% OwnerJul 10, 2020 Sale$27.412,65972,883651,361Jul 14, 2020, 04:40 PM
Marshall Randall10% OwnerJul 13, 2020 Sale$27.132,14558,194649,216Jul 14, 2020, 04:40 PM
Opaleye, L.P.10% OwnerJan 09, 2020 Option Exercise$7.011,426,2349,997,9012,208,472Jan 13, 2020, 06:48 PM
Haines TimothyFormer Director and 10% OwnerNov 12, 2019 Option Exercise$0.99126,645125,9992,144,517Nov 14, 2019, 04:14 PM
Abingworth LLPFormer 10% OwnerNov 12, 2019 Option Exercise$0.99126,645125,9992,144,517Nov 14, 2019, 04:12 PM
Freund John GordonDirectorNov 08, 2019 Option Exercise$0.99703,588700,0002,175,882Nov 12, 2019, 05:00 PM
Toner E. ScottSenior VP of CommercialDec 31, 2018 Option Exercise$1.934,1177,94623,357Jan 03, 2019, 08:20 AM
Kowalsky Matthew PaulVP, Legal and SecretaryDec 31, 2018 Option Exercise$1.932,4484,72529,479Jan 03, 2019, 08:19 AM
Eldridge, George ArthurSr VP, CFO, Treasr, Asst SecyDec 31, 2018 Option Exercise$1.932,4484,72529,132Jan 03, 2019, 08:19 AM
Burke Steven KeithSVP and Chief Medical OfficerDec 31, 2018 Option Exercise$1.932,4484,725123,917Jan 03, 2019, 08:19 AM
Toner E. ScottSenior VP of CommercialJun 29, 2018 Option Exercise$1.624,8567,84219,240Jul 03, 2018, 08:24 AM
Kowalsky Matthew PaulVP, Legal and SecretaryJun 29, 2018 Option Exercise$1.6210,00016,15027,031Jul 03, 2018, 08:20 AM
Eldridge, George ArthurSr VP, CFO, Treasr, Asst SecyJun 29, 2018 Option Exercise$1.6210,00016,15026,684Jul 03, 2018, 08:19 AM
Burke Steven KeithSVP and Chief Medical OfficerJun 29, 2018 Option Exercise$1.6210,00016,150121,469Jul 03, 2018, 08:19 AM
NOYES TIMOTHY PPresident and CEOFeb 16, 2018 Option Exercise$2.112,9976,3240Feb 20, 2018, 08:15 AM
NOYES TIMOTHY PPresident and CEOFeb 15, 2018 Option Exercise$2.152,2454,8312,997Feb 16, 2018, 08:15 AM
NOYES TIMOTHY PPresident and CEOFeb 14, 2018 Option Exercise$2.203,5007,7005,242Feb 16, 2018, 08:15 AM
NOYES TIMOTHY PPresident and CEOJan 16, 2018 Option Exercise$2.3610,00023,5708,742Jan 17, 2018, 05:01 PM
Toner E. ScottSenior VP of MarketingDec 29, 2017 Option Exercise$1.305,5317,16814,384Jan 03, 2018, 08:17 AM
Kowalsky Matthew PaulVP, Legal and SecretaryDec 29, 2017 Option Exercise$1.303,9345,09817,031Jan 03, 2018, 08:16 AM
Eldridge, George ArthurSr VP, CFO, Treasr, Asst SecyDec 29, 2017 Option Exercise$1.303,9345,09816,684Jan 03, 2018, 08:16 AM
Burke Steven KeithSVP and Chief Medical OfficerDec 29, 2017 Option Exercise$1.303,9345,098111,469Jan 03, 2018, 08:15 AM
Burke Steven KeithSVP and Chief Medical OfficerDec 15, 2017 Buy$1.8812,00022,560117,535Dec 18, 2017, 05:11 PM
NOYES TIMOTHY PPresident and CEODec 14, 2017 Option Exercise$1.8510,00018,54018,742Dec 15, 2017, 05:01 PM
Flynn James EDirectorNov 30, 2017 Buy$1.75110,557193,475197,424Dec 04, 2017, 05:17 PM
Flynn James EDirectorNov 30, 2017 Sale$1.75110,557193,4750Dec 04, 2017, 05:17 PM
NOYES TIMOTHY PPresident and CEONov 14, 2017 Option Exercise$1.694,3507,33834,392Nov 16, 2017, 05:00 PM
NOYES TIMOTHY PPresident and CEONov 15, 2017 Option Exercise$1.705,6509,61628,742Nov 16, 2017, 05:00 PM
Eldridge, George ArthurSr VP, CFO, Treasr, Asst SecyNov 14, 2017 Buy$1.692954991,545Nov 14, 2017, 05:05 PM
BOHLIN GAREN GDirectorNov 14, 2017 Option Exercise$1.893,8127,20153,312Nov 14, 2017, 05:02 PM
BOHLIN GAREN GDirectorNov 13, 2017 Option Exercise$1.9225,70049,29349,500Nov 14, 2017, 05:02 PM
BOHLIN GAREN GDirectorNov 10, 2017 Option Exercise$1.9623,80046,71923,800Nov 14, 2017, 05:02 PM
NOYES TIMOTHY PPresident and CEOOct 16, 2017 Option Exercise$2.3110,00023,12038,742Oct 17, 2017, 04:45 PM
NOYES TIMOTHY PPresident and CEOSep 14, 2017 Option Exercise$1.454,8547,05853,888Sep 18, 2017, 04:15 PM
NOYES TIMOTHY PPresident and CEOSep 15, 2017 Option Exercise$1.485,1467,61148,742Sep 18, 2017, 04:15 PM
Toner E. ScottSenior VP of MarketingJun 30, 2017 Option Exercise$1.308,71811,2998,853Jul 05, 2017, 04:11 PM
Eldridge, George ArthurSr VP, CFO, Treasr, Asst SecyJun 30, 2017 Option Exercise$1.3010,00012,96012,750Jul 05, 2017, 04:11 PM
Kowalsky Matthew PaulVP, Legal and SecretaryJun 30, 2017 Option Exercise$1.3010,00012,96013,097Jul 05, 2017, 12:00 AM
Burke Steven KeithSVP and Chief Medical OfficerJun 30, 2017 Option Exercise$1.3010,00012,960105,535Jul 05, 2017, 12:00 AM
Burke Steven KeithSVP and Chief Medical OfficerMar 10, 2017 Option Exercise$1.4670,221102,81995,535Mar 13, 2017, 05:00 PM
Eldridge, George ArthurSr VP, CFO, Treasurer, Sec.Jun 06, 2016 Buy$5.771,2507,215425Jun 07, 2016, 07:49 AM
Eldridge, George ArthurSr VP, CFO, Treasurer, Sec.Jun 06, 2016 Buy$5.782,75015,8952,750Jun 07, 2016, 07:49 AM
NOYES TIMOTHY PPresident and CEOApr 12, 2016 Option Exercise$1.9158,742112,19758,742Apr 13, 2016, 05:05 PM
Toner E. ScottSenior VP of MarketingDec 31, 2015 Option Exercise$13.181852,438185Jan 05, 2016, 04:17 PM
NOYES TIMOTHY PPresident and CEOJan 04, 2016 Option Exercise$1.915,0009,5505,000Jan 05, 2016, 04:16 PM
NOYES TIMOTHY PPresident and CEOJan 04, 2016 Sale$13.885,00069,4000Jan 05, 2016, 04:16 PM
Gottlieb Daniel PhilipVP Corporate DevelopmentDec 31, 2015 Option Exercise$13.182443,216244Jan 05, 2016, 04:15 PM
NOYES TIMOTHY PPresident and CEODec 01, 2015 Option Exercise$1.915,0009,5505,000Dec 02, 2015, 04:31 PM
NOYES TIMOTHY PPresident and CEODec 01, 2015 Sale$14.975,00074,8500Dec 02, 2015, 04:31 PM
NOYES TIMOTHY PPresident and CEONov 02, 2015 Option Exercise$1.915,0009,5505,000Nov 03, 2015, 04:40 PM
NOYES TIMOTHY PPresident and CEONov 02, 2015 Sale$13.505,00067,5000Nov 03, 2015, 04:40 PM
NOYES TIMOTHY PPresident and CEOOct 01, 2015 Option Exercise$1.915,0009,5505,000Oct 02, 2015, 04:45 PM
NOYES TIMOTHY PPresident and CEOOct 01, 2015 Sale$13.335,00066,6500Oct 02, 2015, 04:45 PM
NOYES TIMOTHY PPresident and CEOSep 08, 2015 Option Exercise$1.915,0009,5505,000Sep 10, 2015, 05:00 PM
NOYES TIMOTHY PPresident and CEOSep 08, 2015 Sale$13.555,00067,7500Sep 10, 2015, 05:00 PM
Gottlieb Daniel PhilipVP Marketing & Bus DevelopmentJun 30, 2015 Option Exercise$8.841,96517,3711,965Jul 08, 2015, 08:00 AM
Gottlieb Daniel PhilipVP Marketing & Bus DevelopmentJul 07, 2015 Sale$16.861,96533,1300Jul 08, 2015, 08:00 AM
Burke Steven KeithSVP & Chief Medical OfficerJun 30, 2015 Option Exercise$8.842,40321,24332,814Jul 08, 2015, 08:00 AM
Birner HubertDirectorOct 27, 2014 Buy$10.0076,590765,900300,000Oct 30, 2014, 08:30 AM
Birner HubertDirectorOct 27, 2014 Buy$10.00223,4102,234,100223,410Oct 30, 2014, 08:30 AM
Birner HubertDirectorOct 27, 2014 Option Exercise$4.6039,932183,7791,943,059Oct 30, 2014, 08:30 AM
Birner HubertDirectorOct 27, 2014 Option Exercise$4.60116,511536,2191,903,127Oct 30, 2014, 08:30 AM
TVM Life Science Ventures VI GmbH & Co KG10% OwnerOct 27, 2014 Buy$10.0076,590765,900300,000Oct 30, 2014, 08:23 AM
TVM Life Science Ventures VI GmbH & Co KG10% OwnerOct 27, 2014 Buy$10.00223,4102,234,100223,410Oct 30, 2014, 08:23 AM
TVM Life Science Ventures VI GmbH & Co KG10% OwnerOct 27, 2014 Option Exercise$4.6039,932183,7791,943,059Oct 30, 2014, 08:23 AM
TVM Life Science Ventures VI GmbH & Co KG10% OwnerOct 27, 2014 Option Exercise$4.60116,511536,2191,903,127Oct 30, 2014, 08:23 AM
Skyline Venture Partners Qualified Purchaser Fund IV L P10% OwnerOct 27, 2014 Buy$10.00200,0002,000,000200,000Oct 29, 2014, 07:35 PM
Skyline Venture Partners Qualified Purchaser Fund IV L P10% OwnerOct 27, 2014 Sale$10.0056,038560,3801,432,930Oct 29, 2014, 07:35 PM
Skyline Venture Partners Qualified Purchaser Fund IV L P10% OwnerOct 27, 2014 Option Exercise$4.60121,760560,3761,488,968Oct 29, 2014, 07:35 PM
Abingworth LLP10% OwnerOct 27, 2014 Buy$10.00950,0009,500,000950,000Oct 29, 2014, 07:31 PM
Freund John GordonDirectorOct 27, 2014 Buy$10.00200,0002,000,000200,000Oct 29, 2014, 07:04 PM
Freund John GordonDirectorOct 27, 2014 Sale$10.0056,038560,3801,432,930Oct 29, 2014, 07:04 PM
Freund John GordonDirectorOct 27, 2014 Option Exercise$4.60121,760560,3761,488,968Oct 29, 2014, 07:04 PM
Pharmstandard International S.A.10% OwnerOct 27, 2014 Buy$10.00600,0006,000,000600,000Oct 29, 2014, 06:42 PM
Haines TimothyDirectorOct 27, 2014 Buy$10.00950,0009,500,000950,000Oct 29, 2014, 06:38 PM
Kobyzev DmitryDirectorOct 27, 2014 Buy$10.00600,0006,000,000600,000Oct 29, 2014, 06:02 PM
O'Leary BrendanDirectorOct 27, 2014 Buy$10.0083,170831,7001,387,198Oct 29, 2014, 04:56 PM
Flynn James E10% OwnerOct 27, 2014 Buy$10.00121,3321,213,320208,345Oct 27, 2014, 07:12 PM
Flynn James E10% OwnerOct 27, 2014 Buy$10.00469,4954,694,950876,391Oct 27, 2014, 07:12 PM
Flynn James E10% OwnerOct 27, 2014 Buy$10.00100,8861,008,860170,371Oct 27, 2014, 07:12 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Shefferman JesseCEO and President01/19/202414,904
Bandari JathinChief Medical Officer01/19/20245,499
Zummo JacquelineChf Scientific Operations Off01/19/20245,824
Fry HannahVP, Controller01/19/20241,727
Shefferman JesseCEO and President01/10/202413,733
Zummo JacquelineChf Scientific Operations Off01/10/202412,497
Bandari JathinChief Medical Officer01/10/20244,486
Zummo JacquelineChf Scientific Operations Off01/03/20244,121
Shefferman JesseCEO and President01/03/202412,673
Fry HannahVP, Controller01/03/2024703
Fry HannahVP, Controller07/17/202325,792
Bandari JathinChief Medical Officer07/03/20231,678
Zummo JacquelineChf Scientific Operations Off01/10/202315,675
Shefferman JesseCEO and President01/10/202317,565
Bandari JathinChief Medical Officer01/10/20235,628
Zummo JacquelineChf Scientific Operations Off01/03/20236,045
Shefferman JesseCEO and President01/03/202318,491
Fry HannahVP, Controller01/03/20231,011
Opaleye Management Inc.10% Owner12/30/20226,236
Opaleye Management Inc.10% Owner12/30/202235,713
Opaleye Management Inc.10% Owner09/15/202219,000
Opaleye Management Inc.10% Owner09/14/20229,950
Opaleye Management Inc.10% Owner09/14/202256,118
Opaleye Management Inc.10% Owner09/15/20228,740
Shefferman JesseCEO and President08/11/202234,810
Davis BlaineChief Financial Officer07/15/202215,904
Bandari JathinChief Medical Officer07/01/20222,196
BESHAR LUKE MDirector06/30/202231,000
Opaleye Management Inc.10% Owner04/08/202211,841
Opaleye Management Inc.10% Owner04/08/202225,523
Opaleye Management Inc.10% Owner04/07/20224,743
Opaleye Management Inc.10% Owner04/07/20226,380
Opaleye Management Inc.10% Owner04/08/202225,523
Opaleye Management Inc.10% Owner04/07/20224,743
Opaleye Management Inc.10% Owner04/07/20226,380
Opaleye Management Inc.10% Owner04/08/202211,841
BESHAR LUKE MDirector03/14/202242,500
BESHAR LUKE MDirector03/10/202244,555
Opaleye Management Inc.10% Owner01/28/202220,007
Opaleye Management Inc.10% Owner01/28/202299,264
Zummo JacquelineChf Scientific Operations Off01/10/202228,861
Shefferman JesseCEO and President01/10/202231,852
Opaleye Management Inc.10% Owner12/29/202131,408
Opaleye Management Inc.10% Owner12/28/202134,973
Opaleye Management Inc.10% Owner12/28/202110,117
Opaleye Management Inc.10% Owner12/23/20215,280
Opaleye Management Inc.10% Owner12/23/20213,300
Opaleye Management Inc.10% Owner12/27/202132,659
Opaleye Management Inc.10% Owner12/27/2021207,055
Opaleye Management Inc.10% Owner12/20/20214,562
Opaleye Management Inc.10% Owner12/16/202141,670
Opaleye Management Inc.10% Owner12/17/20213,234
Opaleye Management Inc.10% Owner12/17/202115,180
Opaleye Management Inc.10% Owner12/16/20216,815
Opaleye Management Inc.10% Owner11/18/20216,979
Opaleye Management Inc.10% Owner11/18/202199,151
Opaleye Management Inc.10% Owner11/17/20217,608
Opaleye Management Inc.10% Owner11/17/202156,035
Opaleye Management Inc.10% Owner11/04/20213,621
Opaleye Management Inc.10% Owner11/04/202139,000
Zummo JacquelineChf Scientific Operations Off01/11/202198,457
Shefferman JesseCEO and President01/11/2021107,260
Opaleye Management Inc.10% Owner09/30/2020800,000
Opaleye Management Inc.10% Owner09/24/20203,374,000
Opaleye Management Inc.10% Owner09/24/20201,687,000
Davis BlaineChief Financial Officer09/22/202025,038
Marshall RandallFormer 10% Owner09/14/202049,541
Marshall Randall10% Owner09/10/20204,302
Marshall Randall10% Owner09/09/2020190,766
Marshall Randall10% Owner09/08/202058,866
Marshall Randall10% Owner09/03/20201,050
Marshall Randall10% Owner09/02/20204,281
Marshall Randall10% Owner08/28/202017,031
Marshall Randall10% Owner08/27/202013,780
Marshall Randall10% Owner08/26/202031,763
Marshall Randall10% Owner08/25/202055,939
Marshall Randall10% Owner08/24/202022,558
Marshall Randall10% Owner08/20/202012,333
Marshall Randall10% Owner08/18/20205,038
Marshall Randall10% Owner08/17/202038,870
Marshall Randall10% Owner08/14/202017,563
Marshall Randall10% Owner07/30/202034,426
Marshall Randall10% Owner07/29/202066,483
Marshall Randall10% Owner07/28/2020781,797
Marshall Randall10% Owner07/27/20208,815
Marshall Randall10% Owner07/24/20207,800
Marshall Randall10% Owner07/23/202054,369
Marshall Randall10% Owner07/22/202036,675
Marshall Randall10% Owner07/21/20205,923
Marshall Randall10% Owner07/20/202073,327
Marshall Randall10% Owner07/17/202042,683
Marshall Randall10% Owner07/10/202072,883
Marshall Randall10% Owner07/13/202058,194
Opaleye, L.P.10% Owner01/09/20209,997,901
Haines TimothyFormer Director and 10% Owner11/12/2019125,999
Abingworth LLPFormer 10% Owner11/12/2019125,999
Freund John GordonDirector11/08/2019700,000
Toner E. ScottSenior VP of Commercial12/31/20187,946
Kowalsky Matthew PaulVP, Legal and Secretary12/31/20184,725
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy12/31/20184,725
Burke Steven KeithSVP and Chief Medical Officer12/31/20184,725
Toner E. ScottSenior VP of Commercial06/29/20187,842
Kowalsky Matthew PaulVP, Legal and Secretary06/29/201816,150
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy06/29/201816,150
Burke Steven KeithSVP and Chief Medical Officer06/29/201816,150
NOYES TIMOTHY PPresident and CEO02/16/20186,324
NOYES TIMOTHY PPresident and CEO02/15/20184,831
NOYES TIMOTHY PPresident and CEO02/14/20187,700
NOYES TIMOTHY PPresident and CEO01/16/201823,570
Toner E. ScottSenior VP of Marketing12/29/20177,168
Kowalsky Matthew PaulVP, Legal and Secretary12/29/20175,098
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy12/29/20175,098
Burke Steven KeithSVP and Chief Medical Officer12/29/20175,098
Burke Steven KeithSVP and Chief Medical Officer12/15/201722,560
NOYES TIMOTHY PPresident and CEO12/14/201718,540
Flynn James EDirector11/30/2017193,475
Flynn James EDirector11/30/2017193,475
NOYES TIMOTHY PPresident and CEO11/14/20177,338
NOYES TIMOTHY PPresident and CEO11/15/20179,616
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy11/14/2017499
BOHLIN GAREN GDirector11/14/20177,201
BOHLIN GAREN GDirector11/13/201749,293
BOHLIN GAREN GDirector11/10/201746,719
NOYES TIMOTHY PPresident and CEO10/16/201723,120
NOYES TIMOTHY PPresident and CEO09/14/20177,058
NOYES TIMOTHY PPresident and CEO09/15/20177,611
Toner E. ScottSenior VP of Marketing06/30/201711,299
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy06/30/201712,960
Kowalsky Matthew PaulVP, Legal and Secretary06/30/201712,960
Burke Steven KeithSVP and Chief Medical Officer06/30/201712,960
Burke Steven KeithSVP and Chief Medical Officer03/10/2017102,819
Eldridge, George ArthurSr VP, CFO, Treasurer, Sec.06/06/20167,215
Eldridge, George ArthurSr VP, CFO, Treasurer, Sec.06/06/201615,895
NOYES TIMOTHY PPresident and CEO04/12/2016112,197
Toner E. ScottSenior VP of Marketing12/31/20152,438
NOYES TIMOTHY PPresident and CEO01/04/20169,550
NOYES TIMOTHY PPresident and CEO01/04/201669,400
Gottlieb Daniel PhilipVP Corporate Development12/31/20153,216
NOYES TIMOTHY PPresident and CEO12/01/20159,550
NOYES TIMOTHY PPresident and CEO12/01/201574,850
NOYES TIMOTHY PPresident and CEO11/02/20159,550
NOYES TIMOTHY PPresident and CEO11/02/201567,500
NOYES TIMOTHY PPresident and CEO10/01/20159,550
NOYES TIMOTHY PPresident and CEO10/01/201566,650
NOYES TIMOTHY PPresident and CEO09/08/20159,550
NOYES TIMOTHY PPresident and CEO09/08/201567,750
Gottlieb Daniel PhilipVP Marketing & Bus Development06/30/201517,371
Gottlieb Daniel PhilipVP Marketing & Bus Development07/07/201533,130
Burke Steven KeithSVP & Chief Medical Officer06/30/201521,243
Birner HubertDirector10/27/2014765,900
Birner HubertDirector10/27/20142,234,100
Birner HubertDirector10/27/2014183,779
Birner HubertDirector10/27/2014536,219
TVM Life Science Ventures VI GmbH & Co KG10% Owner10/27/2014765,900
TVM Life Science Ventures VI GmbH & Co KG10% Owner10/27/20142,234,100
TVM Life Science Ventures VI GmbH & Co KG10% Owner10/27/2014183,779
TVM Life Science Ventures VI GmbH & Co KG10% Owner10/27/2014536,219
Skyline Venture Partners Qualified Purchaser Fund IV L P10% Owner10/27/20142,000,000
Skyline Venture Partners Qualified Purchaser Fund IV L P10% Owner10/27/2014560,380
Skyline Venture Partners Qualified Purchaser Fund IV L P10% Owner10/27/2014560,376
Abingworth LLP10% Owner10/27/20149,500,000
Freund John GordonDirector10/27/20142,000,000
Freund John GordonDirector10/27/2014560,380
Freund John GordonDirector10/27/2014560,376
Pharmstandard International S.A.10% Owner10/27/20146,000,000
Haines TimothyDirector10/27/20149,500,000
Kobyzev DmitryDirector10/27/20146,000,000
O'Leary BrendanDirector10/27/2014831,700
Flynn James E10% Owner10/27/20141,213,320
Flynn James E10% Owner10/27/20144,694,950
Flynn James E10% Owner10/27/20141,008,860
Load More Insider Transactions
FUNDS WITH A POSITION IN PROTARA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP199,6710.00426%No changeOther
RENAISSANCE TECHNOLOGIES LLC113,3000.00033%88.52%Other
GEODE CAPITAL MANAGEMENT, LLC78,5180.00002%No changeOther
BLACKROCK INC.34,3160%-0.83%Other
CHANGE IN SHARES OUTSTANDING FOR PROTARA THERAPEUTICS INC
STOCK BUYBACKS FOR PROTARA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.15%
1Q
12/31/2023
06/30/2023
0.51%
2Q
12/31/2023
03/31/2023
0.54%
3Q
12/31/2023
12/31/2022
0.87%
4Q
12/31/2023
09/30/2022
0.89%
5Q
12/31/2023
06/30/2022
0.98%
6Q
12/31/2023
03/31/2022
1.02%
7Q
12/31/2023
12/31/2021
1.15%
8Q
12/31/2023
09/30/2021
1.15%
9Q
12/31/2023
06/30/2021
1.19%
10Q
12/31/2023
03/31/2021
1.23%
11Q
12/31/2023
12/31/2020
57.11%
12Q
12/31/2023
09/30/2020
79.71%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.15%
1Q
06/30/2023
0.51%
2Q
03/31/2023
0.54%
3Q
12/31/2022
0.87%
4Q
09/30/2022
0.89%
5Q
06/30/2022
0.98%
6Q
03/31/2022
1.02%
7Q
12/31/2021
1.15%
8Q
09/30/2021
1.15%
9Q
06/30/2021
1.19%
10Q
03/31/2021
1.23%
11Q
12/31/2020
57.11%
12Q
09/30/2020
79.71%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PROTARA THERAPEUTICS INC
LOADING...